Crisnatol

Chemical compound
  • none
Identifiers
  • 2-(Chrysen-6-ylmethylamino)-2-methylpropane-1,3-diol
CAS Number
  • 96389-68-3 checkY
PubChem CID
  • 57062
ChemSpider
  • 51449 checkY
UNII
  • 2J71UR51UE
CompTox Dashboard (EPA)
  • DTXSID10242217 Edit this at Wikidata
Chemical and physical dataFormulaC23H23NO2Molar mass345.442 g·mol−13D model (JSmol)
  • Interactive image
  • CC(CO)(CO)NCc1cc2c3ccccc3ccc2c4c1cccc4
InChI
  • InChI=InChI=1S/C23H23NO2/c1-23(14-25,15-26)24-13-17-12-22-18-7-3-2-6-16(18)10-11-21(22)20-9-5-4-8-19(17)20/h2-12,24-26H,13-15H2,1H3 checkY
  • Key:SBRXTSOCZITGQG-UHFFFAOYSA-N checkY

Crisnatol (BW-A770U) is an experimental anticancer agent.[1] A Phase I clinical trial was published in 1999.[2]

References

  1. ^ U.S. patent 4,719,046
  2. ^ Villalona-Calero MA, Petit T, Kuhn J, Cobb P, Kraynak M, Eckhardt SG, et al. (November 1999). "A phase I and pharmacological study of protracted infusions of crisnatol mesylate in patients with solid malignancies". Clinical Cancer Research. 5 (11): 3369–78. PMID 10589747.
  • v
  • t
  • e
Intracellular chemotherapeutic agents / antineoplastic agents (L01)
SPs/MIs
(M phase)
Block microtubule assembly
Block microtubule disassembly
DNA replication
inhibitor
DNA precursors/
antimetabolites
(S phase)
Folic acid
Purine
Pyrimidine
Deoxyribonucleotide
Topoisomerase inhibitors
(S phase)
I
II
II+Intercalation
Crosslinking of DNA
(CCNS)
Alkylating
Platinum-based
Nonclassical
Intercalation
Photosensitizers/PDTOther
Enzyme inhibitors
Receptor antagonists
Other/ungrouped
Stub icon

This antineoplastic or immunomodulatory drug article is a stub. You can help Wikipedia by expanding it.

  • v
  • t
  • e